The role of retinoblastoma protein in apoptosis

Apoptosis

Volumn 4, Issue 1, 1999, Pages 21-29

  Fan, G ^a   Steer, C J ^a  

^a UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

Author keywords

Apoptosis; Cell cycle; E2F transcription factor; Nuclear phosphoprotein; Retinoblastoma; Transforming growth factor beta; Tumour suppressor gene

Indexed keywords

PROTEIN BCL 2; PROTEIN P53; TRANSCRIPTION FACTOR E2F;

APOPTOSIS; CARCINOGENESIS; CELL DIFFERENTIATION; GENE EXPRESSION REGULATION; GROWTH REGULATION; HUMAN; PRIORITY JOURNAL; PROTEIN DETERMINATION; REVIEW; TUMOR SUPPRESSOR GENE;

EID: 0032775343     PISSN: 13608185     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1009626031179     Document Type: Review

References (72)

1. Lee EY-HP, Chang C-Y, Hu N, et al. Mice deficient for Rb are nonviable and show defects in neurogenesis and haematopoiesis. Nature 1992; 359: 288-294.
2. Slack RS, Miller FD. Retinoblastoma gene in mouse neural development. Dev Genetics 1996; 18: 81-91.
3. Zacksenhaus E, Jiang Z, Chung D, Marth JD, Phillips RA, Gallie BL. pRb controls proliferation, differentiation, and death of skeletal muscle cells and other lineages during embryogenesis. Genes Dev 1996; 10: 3051-3064.
4. Pan H, Griep AE. Altered cell cycle regulation in the lens of HPV-16 E6 or E7 transgenic mice: Implications for tumor suppresser gene function in development. Genes Dev 1994; 8: 1285-1299.
5. Fan G, Ma X, Kren BT, Steer CJ. The retinoblastoma gene product inhibits TGF-β1 induced apoptosis in primary rat hepatocytes and human HuH-7 hepatoma cells. Oncogene 1996; 12: 1909-1919.
6. Wang JYJ. Retinoblastoma protein in growth suppression and death protection. Curr Opin Gen Dev 1997; 7: 39-45.
7. Fan G, Xu R, Wessendorf MW, Ma X, Kren BT, Steer CJ. Modulation of retinoblastoma and retinoblastoma-related proteins in regenerating rat liver and primary hepatocytes. Cell Growth Differ 1995; 6: 1463-1476.
8. Fan G, Steer CJ. The retinoblastoma gene product is a negative modulator of the apoptotic pathway. Advan Enzyme Regul 1996; 36: 283-303.
9. Fan G, Kren BT, Steer CJ. Regulation of apoptosis-associated genes in the regenerating liver. Sem Liver Dis 1998; 18: 123-140.
10. Oberhammer FA, Pavelka M, Sharma S, et al. Induction of apoptosis in cultured hepatocytes and in regressing liver by transforming growth factor β1. Proc Natl Acad Sci USA 1992; 89: 5408-5412.
11. Takiya S, Tagaya T, Takahashi K, et al. Role of transforming growth factor β1 on hepatic regeneration and apoptosis in liver disease. J Clin Path 1995; 48: 1093-1097.
12. Almasan A, Yin Y, Kelly RE, et al. Deficiency of retinoblastoma protein leads to inappropriate S-phase entry, activation of E2F-responsive genes, and apoptosis. Proc Natl Acad Sci USA 1995; 92: 5436-5440.
13. Massagué J. The transforming growth factor-β family. Ann Rev Cell Biol 1990; 6: 597-641.
14. Baker JC, Harland RM. From receptor to nucleus: the Smad pathway. Curr Opin Gen Dev 1997; 7: 467-473.
15. Toyoshima H, Hunter T. p27, a novel inhibitor of G1 cyclin-Cdk protein kinase activity, is related to p21. Cell 1994; 78: 67-74.
16. Reynisdóttir I, Polyak K, Iavarone A, Massagué J. Kip/Cip and Ink4 Cdk inhibitors cooperate to induce cell cycle arrest in response to TGF-β. Genes Dev 1995; 9: 1831-1845.
17. Yuan J. Transducing signals of life and death. Curr Opin Cell Biol 1997; 9: 247-251.
18. Itoh N, Nagata S. A novel protein domain required for apoptosis. Mutational analysis of human Fas antigen. J Biol Chem 1993; 268: 10932-10937.
19. Darnay BG, Aggarwal BB. Early events in TNF signaling: a story of associations and dissociations. J Leukoc Biol 1997; 61: 559-566.
20. Darnay BG, Reddy SAG, Aggarwal BB. Identification of a protein kinase associated with the cytoplasmic domain of the p60 tumor necrosis factor receptor. J Biol Chem 1994; 269: 20299-20304.
21. Liu Z-g, Hsu H, Goeddel DV, Karin M. Dissection of TNF receptor 1 effector function: JNK activation is not linked to apoptosis while NF-κB activation prevents cell death. Cell 1996; 87: 565-576.
22. An B, Dou QP. Cleavage of retinoblastoma protein during apoptosis: an interleukin β-converting enzyme-like protease as candidate. Cancer Res 1996; 56: 438-442.
23. Fattman CL, An B, Dou QP. Characterization of interior cleavage of retinoblastomaprotein in apoptosis. J Cell Biochem 1997; 67: 399-408.
24. Jänicke RU, Walker PA, Lin XY, Porter AG. Specific cleavage of the retinoblastoma protein by an ICE-like protease in apoptosis. EMBO J 1996; 15: 6969-6978.
25. Chen W-d, Otterson GA, Lipkowitz S, Khleif SN, Coxon AB, Kaye FJ. Apoptosis is associated with cleavage of a 5 kDa fragment from RB which mimics dephosphorylation and modulates E2F binding. Oncogene 1997; 14: 1243-1248.
26. Tan X, Wang JYJ. The caspase-RB connection in cell death. Trends Cell Biol 1998; 8: 116-120.
27. Gottlieb E, Oren M. p53 facilitates pRb cleavage in IL-3-deprived cells: novel pro-apoptotic activity of p53. EMBO J 1998; 17: 3587-3596.
28. Tan X, Martin SJ, Green DR, Wang JYJ. Degradation of retinoblastoma protein in tumor necrosis factor- and CD95-induced cell death. J Biol Chem 1997; 272: 9613-9616.
29. Wu X, Levine AJ. p53 and E2F-1 cooperate to mediate apoptosis. Proc Natl Acad Sci USA 1994; 91: 3602-3606.
30. Hsieh J-K, Fredersdorf S, Kouzarides T, Martin K, Lu X. E2F1-induced apoptosis requires DNA binding but not transactivation and is inhibited by the retinoblastoma protein through direct interaction. Genes Dev 1997; 11: 1840-1852.
31. Haas-Kogan DA, Kogan SC, Levi D, et al. Inhibition of apoptosis by the retinoblastoma gene product. EMBO J 1995; 14: 461-472.
32. Berry DE, Lu Y, Schmidt B, et al. Retinoblastoma protein inhibits IFN-γ induced apoptosis. Oncogene 1996; 12: 1809-1819.
33. McConkey DJ, Goodrich D, Bucana C, Klostergaard J. The human retinoblastoma gene product suppresses ceramide-induced apoptosis in human bladder tumor cells. Oncogene 1996; 13: 1693-1700.
34. Haupt Y, Rowan S, Oren M. p53-mediated apoptosis in Hela cells can be overcome by excess pRB. Oncogene 1995; 10: 1563-1571.
35. Fan G, Ma X, Kren BT, Rice M, Kmiec EB, Steer CJ. A novel link between REC2, a DNA recombinase, the retinoblastoma protein, and apoptosis. J Biol Chem 1997; 272: 19413-19417.
36. Taya Y. RB kinases and RB-binding proteins: new points of view. Trends Biol Sci (TIBS) 1997; 22: 14-17.
37. Herwig S, Strauss M. The retinoblastoma protein: a master regulator of cell cycle, differentiation and apoptosis. Eur J Biochem 1997; 246: 581-601.
38. Bartek J, Bartkova J, Lukas J. The retinoblastoma protein pathway and the restriction point. Curr Opin Cell Biol 1996; 8: 805-814.
39. Resnitzky D, Reed SI. Different roles for cyclins D1 and E in regulation of the G1-to-S transition. Mol Cell Biol 1995; 15: 3463-3469.
40. 1-to-S phase transition. Mol Cell Biol 1995; 15: 2612-2624.
41. Knudsen ES, Wang JYJ. Differential regulation of retinoblastoma protein function by specific Cdk phosphorylation sites. J Biol Chem 1996; 271: 8313-8320.
42. 2/M phases. J Biol Chem 1995; 270: 9281-9288.
43. Field SJ, Tsai F-Y, Kuo F, et al. E2F-1 functions in mice to promote apoptosis and suppress proliferation. Cell 1996; 85: 549-561.
44. Sofer-Levi Y, Resnitzky D. Apoptosis induced by ectopic expression of cyclin D1 but not cyclin E. Oncogene 1996; 13: 2431-2437.
45. Yuan Z-M, Huang Y, Ishiko T, Kharbanda S, Weichselbaum R, Kufe D. Regulation of DNA damage-induced apoptosis by the c-Abl tyrosine kinase. Proc Natl Acad Sci USA 1997; 94: 1437-1440.
46. Zhu M-S, Liu D-G, Cheng H-Q, Xu X-Y, Li Z-P. Expression of exogenous NF-IL6 induces apoptosis in Sp2/0-Ag14 myeloma cells. DNA Cell Biol 1997; 16: 127-135.
47. Hueber A-O, Zornig M, Lyon D, Suda T, Nagata S, Evan GI. Requirement for the CD95 receptor-ligand pathway in c-Myc-induced apoptosis. Science 1997; 278: 1305-1309.
48. Ueda K, Ganem D. Apoptosis is induced by N-myc expression in hepatocytes, a frequent event in hepadnavirus oncogenesis, and is blocked by insulin-like growth factor II. J Virol 1996; 70: 1375-1383.
49. Casiano CA, Tan EM. Antinuclear autoantibodies: probes for defining proteolytic events associated with apoptosis. Mol Biol Rep 1996; 23: 211-216.
50. Piedrafita FJ, Pfahl M. Retinoid-induced apoptosis and Sp1 cleavage occur independently of transcription and require caspase activation. Mol Cell Biol 1997; 17: 6348-6358.
51. Yamada T, Oikawa T. Induction of apoptosis by overexpression of the PU.1/Spi-1 gene in murine erythroleukemia cells. Leukemia 1997; 11(Suppl): 480-481.
52. 1 arrest and apoptosis functions of the p53 tumor suppressor protein. Mol Cell Biol 1996; 16: 2445-2452.
53. Lee K-Y, Helbing CC, Choi K-S, Johnston RN, Wang JH. Neuronal Cdc2-like kinase (Nclk) binds and phosphorylates the retinoblastoma protein. J Biol Chem 1997; 272: 5622-5626.
54. Takahashi A, Alnemri ES, Lazebnik YA, et al. Cleavage of Lamin A by Mch2α but not CPP32: multiple interleukin 1β-converting enzyme-related proteases with distinct substrate recognition properties are active in apoptosis. Proc Natl Acad Sci USA 1996; 93: 8395-8400.
55. Rao L, Perez D, White E. Lamin proteolysis facilitates nuclear events during apoptosis. J Cell Biol 1996; 135: 1441-1455.
56. Meriin AB, Gabai VL, Yaglom J, Shifrin VI, Sherman MY. Proteasome inhibitors activate stress kinases and induce Hsp72. Diverse effects on apoptosis. J Biol Chem 1998; 273: 6373-6379.
57. Rhéaume E, Cohen LY, Uhlmann F, et al. The large subunit of replication factor C is a substrate for caspase-3 in vitro and is cleaved by a caspase-3-like protease during Fas-mediated apoptosis. EMBO J 1997; 16: 6346-6354.
58. Morana SJ, Wolf CM, Li J, Reynolds JE, Brown MK, Eastman A. The involvement of protein phosphatases in the activation of ICE/CED-3 protease, intracellular acidification, DNA digestion, and apoptosis. J Biol Chem 1996; 271: 18263-18271.
59. Dou QP, An B, Antoku K, Johnson DE. Fas stimulation induces RB dephosphorylation and proteolysis that is blocked by inhibitors of the ICE protease family. J Cell Biochem 1997; 64: 586-594.
60. Wang H, Grand RJA, Milner AE, Armitage RJ, Gordon J, Gregory CD. Repression of apoptosis in human B-lymphoma cells by CD40-ligand and Bcl-2: relationship to the cell-cycle and role of the retinoblastoma protein. Oncogene 1996; 13: 373-379.
61. Day ML, Foster RG, Day KC, et al. Cell anchorage regulates apoptosis through the retinoblastoma tumor suppressor/E2F pathway. J Biol Chem 1997; 272: 8125-8128.
62. Qin X-Q, Livingston DM, Kaelin WG Jr, Adams PD. Deregulated transcription factor E2F-1 expression leads to S-phase entry and p53-mediated apoptosis. Proc Natl Acad Sci USA 1994; 91: 10918-10922.
63. Shan B, Durfee T, Lee W-H. Disruption of RB/E2F-1 interaction by single point mutations in E2F-1 enhances S-phase entry and apoptosis. Proc Natl Acad Sci USA 1996; 93: 679-684.
64. Hiebert SW, Packham G, Strom DK, et al. E2F-1:DP-1 induces p53 and overrides survival factors to trigger apoptosis. Mol Cell Biol 1995; 15: 6864-6874.
65. Thut CJ, Goodrich JA, Tjian R. Repression of p53-mediated transcription of MDM2: a dual mechanism. Genes Dev 1997; 11: 1974-1986.
66. Haupt Y, Maya R, Kazaz A, Oren M. Mdm2 promotes the rapid degradation of p53. Nature 1997; 387: 296-299.
67. Haines DS. The mdm2 proto-oncogene. Leuk Lymph 1997; 26: 227-238.
68. Chen L, Marechal V, Moreau J, Levine AJ, Chen J. Proteolytic cleavage of the mdm2 oncoprotein during apoptosis. J Biol Chem 1997; 272: 22966-22973.
69. Erhardt P, Tomaselli KJ, Cooper GM. Identification of the MDM2 oncoprotein as a substrate for CPP32-like apoptotic proteases. J Biol Chem 1997; 272: 15049-15052.
70. Jones DL, Thompson DA, Münger K. Destabilization of the RB tumor suppresser protein and stabilization of p53 contribute to HPV type 16 E7-induced apoptosis. Virology 1997; 239: 97-107.
71. Spinedi A, Amendola A, Di Bartolomeo S, Piacentini M. Ceramide-induced apoptosis is mediated by caspase activation independently from retinoblastoma protein post-translational modification. Biochem Biophys Res Comm 1998; 243: 852-857.
72. Patel T, Roberts LR, Jones BA, Gores GJ. Dysregulation of apoptosis as a mechanism of liver disease: an overview. Sem Liver Disease 1998; 18: 105-114.